Pag-aaral pangklinika para sa Dementia sa New Jersey
8 pag-aaral para sa Dementia ang naghahanap ng mga kalahok sa mga site sa New Jersey.
Mga Lungsod sa New Jersey
Opisyal na teksto ng pag-aaral (English)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, West Long Branch
Nagre-recruitPhase 2
Edad 55 hanggang 90 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06887192Comparison of Two Group Wellness Interventions for Individuals With Neurologic Conditions and Their Support Persons
- Kessler Foundation, East Hanover
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT05048966A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- The Cognitive and Research Center of New Jersey, Springfield
- Advanced Clinical Institute, West Long Branch
Nagre-recruitPhase 3
Edad 60 hanggang 85 · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06976203A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- CenExel AMRI, Toms River
Nagre-recruitPhase 1
Edad 50 hanggang 85 · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT06297590A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Advanced Memory Research Institute of New Jersey, Toms River
Nagre-recruitPhase 3
Edad 60 hanggang 85 · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT06976216A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- The Cognitive and Research Center of New Jersey, Springfield
Nagre-recruitPhase 3
Edad 55 pataas · Lahat ng kasarian · Na-update Hul 7, 2026 · NCT07602582Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol
- Nuclear Imaging Institute, Englewood
Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Abr 13, 2026 · NCT07012993Open-label Extension Study in Participants With Early Alzheimer's Disease
- GSK Investigational Site, Toms River
Nagre-recruitPhase 2
Edad 50 hanggang 85 · Lahat ng kasarian · Na-update Peb 2, 2026 · NCT07105709Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.